Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'22
Dec'21
Net Sales
197.78
7.25
Other Operating Income
0.00
0.00
Total Operating income
197.78
7.25
Raw Material Cost
123.78
13.22
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
Employee Cost
0.00
0.00
Power Cost
0.00
0.00
Manufacturing Expenses
42.19
40.37
Selling and Distribution Expenses
14.46
14.22
Other Expenses
32.31
19.72
Total Expenditure (Excl Depreciation)
503.55
265.02
Operating Profit (PBDIT) excl Other Income
-305.79999999999995
-257.8
Other Income
25.53
15.88
Operating Profit (PBDIT)
-259.84
-233.28
Interest
42.19
40.37
Exceptional Items
0.54
0.04
Gross Profit (PBDT)
74.00
-5.97
Depreciation
20.39
8.61
Profit Before Tax
-321.89
-282.22
Tax
2.22
0.00
Provisions and contingencies
0.00
0.00
Profit After Tax
-288.33
-250.54
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
-288.33
-250.54
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
-288.33
-250.54
Equity Capital
0.00
0.00
Face Value
1.12
1.22
Reserves
-3,622.17
-3,234.17
Earnings per share (EPS)
-1.34
-1.16
Diluted Earnings per share
-1.34
-1.16
Operating Profit Margin (Excl OI)
-154.6%
-3556.28%
Gross Profit Margin
-152.44%
-3774.87%
PAT Margin
-145.78%
-3456.58%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Analysis not available
Compare Quarterly Results Of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(HKD)
Change(%)
Net Sales
197.78
20,808.22
-20,610.44
-99.05%
Other Operating Income
0.00
0.00
0.00
Total Operating income
197.78
20,808.22
-20,610.44
-99.05%
Raw Material Cost
123.78
17,770.55
-17,646.77
-99.30%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
42.19
110.48
-68.29
-61.81%
Selling and Distribution Expenses
14.46
2,099.05
-2,084.59
-99.31%
Other Expenses
32.31
2.96
29.35
991.55%
Total Expenditure (Excl Depreciation)
503.55
20,009.69
-19,506.14
-97.48%
Operating Profit (PBDIT) excl Other Income
-305.77
798.53
-1,104.30
-138.29%
Other Income
25.53
262.64
-237.11
-90.28%
Operating Profit (PBDIT)
-259.84
1,314.08
-1,573.92
-119.77%
Interest
42.19
110.48
-68.29
-61.81%
Exceptional Items
0.54
-1.97
2.51
127.41%
Gross Profit (PBDT)
74.00
3,037.67
-2,963.67
-97.56%
Depreciation
20.39
257.92
-237.53
-92.09%
Profit Before Tax
-321.89
943.71
-1,265.60
-134.11%
Tax
2.22
152.10
-149.88
-98.54%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-288.33
749.77
-1,038.10
-138.46%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-288.33
749.77
-1,038.10
-138.46%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
25.52
-25.52
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-288.33
775.29
-1,063.62
-137.19%
Equity Capital
0
0
0.00
Face Value
1.12
1.10
0.00
Reserves
-3,622.17
41,367.30
-44,989.47
-108.76%
Earnings per share (EPS)
-1.34
0.46
-1.80
-391.30%
Diluted Earnings per share
-1.34
0.46
-1.80
-391.30%
Operating Profit Margin (Excl OI)
-154.60%
3.81%
0.00
-158.41%
Gross Profit Margin
-152.44%
5.77%
0.00
-158.21%
PAT Margin
-145.78%
3.60%
0.00
-149.38%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales NA Million
in Figures in Million
Quarterly - Standalone Net Profit
Standalone Net Profit NA Million
in Figures in Million
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Million
in Figures in Million
Quarterly - Interest
Interest NA Million
in Figures in Million
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in Figures in %
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
